Organization
Hvivo
1 clinical trial
Clinical trial
An Exploratory Study To Establish The Dose, Safety, And Pathogenicity Of A New Influenza B Challenge Strain In Healthy Participants 18 To 55 Years Of AgeStatus: Recruiting, Estimated PCD: 2024-02-02